Cargando…
Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19
BACKGROUND: Coronavirus disease-2019 (COVID-19) ranges from asymptomatic to severe. Several comorbidities are associated with worse clinical outcomes. Antibiotic use is common in COVID-19 and penicillin (PCN) allergy can affect antibiotic choice and may influence COVID-19 outcomes. OBJECTIVE: To inv...
Autores principales: | Kaminsky, Lauren W., Dalessio, Shannon, Al-Shaikhly, Taha, Al-Sadi, Rana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288230/ https://www.ncbi.nlm.nih.gov/pubmed/34293501 http://dx.doi.org/10.1016/j.jaip.2021.06.054 |
Ejemplares similares
-
Clinical Outcomes of COVID-19 in Common Variable Immunodeficiency Patients
por: Nye, Derek, et al.
Publicado: (2022) -
Virtually supported penicillin allergy de-labelling during COVID-19
por: Ghassemian, Arian, et al.
Publicado: (2023) -
Increasing cefazolin use for surgical prophylaxis in penicillin-allergy–labeled patients
por: VanderVelde, Kathryn A., et al.
Publicado: (2023) -
Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
por: Dluzynski, Daniela, et al.
Publicado: (2023) -
Labeling of penicillin allergy in patients admitted to a tertiary hospital in Qatar: A retrospective audit
por: Hasan Elajez, Reem, et al.
Publicado: (2022)